Author

Hisanobu Niitani

Observed names: H NIITANI, H Niitani, HISANOBU NIITANI, M.D, HISANOBU NIITANI, M.D., Hisanobu NIITANI, NIITANI, Hisanobu, Niitani, Hisanobu

Observed institutions: Osaka City University, National Cancer Centre Japan, Niigata Cancer Center Hospital, Osaka City General Hospital, Aichi Cancer Center, Yokohama Municipal Citizen's Hospital, Nippon Medical School Hospital, Kanagawa Cancer Center, National Cancer Center Hospital, Tokyo Cooperative Oncology Group, National Cancer Center Hospital, Nagoya University, The University of Tokyo, Nippon Medical School, Kindai University

OpenAlex ID: A5111380586

Phase III Randomized Trial of Docetaxel Plus Cisplatin Versus Vindesine Plus Cisplatin in Patients With Stage IV Non-Small-Cell Lung Cancer: The Japanese Taxotere Lung Cancer Study Group

2004 · Kaoru Kubota, Koshiro Watanabe, et al. · Journal of Clinical Oncology · 230

PDF

Phase I study of recombinant human tumor necrosis factor

1987 · Kiyoji Kimura, Tetsuo Taguchi, et al. · Cancer Chemotherapy and Pharmacology · 135

S-1 Plus Cisplatin Combination Chemotherapy in Patients with Advanced Non–Small Cell Lung Cancer

2004 · Yukito Ichinose, Kozo Yoshimori, et al. · Clinical Cancer Research · 99

A Phase II study of vinorelbine, a new derivative of vinca alkaloid, for previously untreated advanced non-small cell lung cancer

1994 · Kiyoyuki Furuse, Kaoru Kubota, et al. · Lung Cancer · 81

Phase I study of E7010

1998 · Kaichiro Yamamoto, Kiichiro Noda, et al. · Cancer Chemotherapy and Pharmacology · 65

A comparative trial of LC9018 plus doxorubicin and doxorubicin alone for the treatment of malignant pleural effusion secondary to lung cancer

1991 · Tomiya Masuno, Susumu Kishimoto, et al. · Cancer · 62

PDF

Phase I and Pharmacologic Study of Docetaxel and Irinotecan in Advanced Non–Small-Cell Lung Cancer

2000 · Noriyuki Masuda, Shunichi Negoro, et al. · Journal of Clinical Oncology · 39

Experimental and clinical effect of ACNU in Japan, with emphasis on small-cell carcinoma of the lung

1980 · Nagahiro Saijo, Hisanobu Niitani · Cancer Chemotherapy and Pharmacology · 32

Phase I study of TZT‐1027, a novel synthetic dolastatin 10 derivative and inhibitor of tubulin polymerization, given weekly to advanced solid tumor patients for 3 weeks

2008 · Nobuyuki Yamamoto, Masahiro Andoh, et al. · Cancer Science · 30

PDF

A Phase II Study of Topotecan in Patients with Relapsed Small-Cell Lung Cancer

2003 · Koji Takeda, Shunichi Negoro, et al. · Clinical Lung Cancer · 29

UFT plus cisplatin combination chemotherapy in the treatment of patients with advanced nonsmall cell lung carcinoma

2000 · Yukito Ichinose, Kozo Yosimori, et al. · Cancer · 29

Docetaxel in Combination with Either Cisplatin or Gemcitabine in Unresectable Non-small Cell Lung Carcinoma: A Randomized Phase II Study by the Japan Lung Cancer Cooperative Clinical Study Group

2006 · Nobuyuki Katakami, Yuichi Takiguchi, et al. · Journal of Thoracic Oncology · 27

PDF

Reversal of multidrug resistance by tyrosine‐kinase inhibitors in a non‐P‐glycoprotein‐mediated multidrug‐resistant cell line

1994 · Yuichiro Takeda, Kazuto Nishio, et al. · International Journal of Cancer · 27

Pooled analysis of S-1 trials in non-small cell lung cancer according to histological type.

2010 · Nobuyuki Yamamoto, Takeharu Yamanaka, et al. · PubMed · 24

Activity of gemcitabine in non-small-cell lung cancer: results of the Japan gemcitabine group (A) phase II study

1997 · Minoru Takada, Shun-ichi Negoro, et al. · Cancer Chemotherapy and Pharmacology · 23

Clinicopathologic and Immunohistochemical Characteristics of Goblet Cell Type Adenocarcinoma of the Lung

1991 · Akihiko Gemma, Masayuki Noguchi, et al. · Acta Pathologica Japonica · 23

Effects of sodium thiosulfate in combination therapy of cis-dichlorodiammineplatinum and vindesine

1989 · Akira Hirosawa, Hisanobu Niitani, et al. · Cancer Chemotherapy and Pharmacology · 23

Activity of gemcitabine in the treatment of patients with non-small cell lung cancer: a multicenter phase II study

1997 · Akira Yokoyama, Yushi Nakai, et al. · Anti-Cancer Drugs · 22

Uracil/Tegafur Plus Cisplatin with Concurrent Radiotherapy for Locally Advanced Non-Small-Cell Lung Cancer

2004 · Yukito Ichinose, Yushi Nakai, et al. · Clinical Cancer Research · 19

Cisplatin/Carboplatin Therapy in Non-Small Cell Lung Cancer

2009 · Hisanobu Niitani, Kunihiko Kobayashi · Oncology · 16

In vitro investigation of a combination of two drugs, cisplatin and carboplatin, as a function of the area under thec/t curve

1995 · Kunihiko Kobayashi, Shoji Kudoh, et al. · Journal of Cancer Research and Clinical Oncology · 15

Establishment of a human leukemia subline resistant to the growth‐inhibitory effect of 12‐o‐tetradecanoylphorbol 13‐acetate (TPA) and showing non‐P‐glycoprotein‐mediated multi‐drug resistance

1991 · Yuichiro Takeda, Kazuto Nishio, et al. · International Journal of Cancer · 15

Efficacy of a New 5-Fluorouracil Derivative, Bof-A2, in Advanced Non-Small Cell Lung Cancer a Multi-Center Phase Ii Study

1994 · Yushi Nakai, Kiyoyuki Furuse, et al. · Acta Oncologica · 14

PDF

Kinetic Analysis of Combination Effect of Navelbine (KW‐2307) with Cisplatin against Human Lung Adenocarcinoma PC‐12 Cells in Culture

1992 · Katsushige Gomi, Hiroe Ohno, et al. · Japanese Journal of Cancer Research · 14

Absorption and Excretion of a New Oral Antitumor Drug, 1-Hexylcarbamoyl-5-Fluorouracil (HCFU), in Cancer Patients

1980 · Yasuo Koyama, Hisanobu Niitani, et al. · Japanese Journal of Clinical Oncology · 13

Works count: 85

Citation count: 1,263

H-index: 19

I10-index: 27